Biovian

Biovian is a leading biopharmaceuticals development and manufacturing organization providing “one-stop-shop” services, from early development to finished vial, for biological processes such as complex microbial fermentation and gene therapy. Biovian has prestigious customers across the globe and is headquartered in Turku, Finland. Keensight Capital provided an equity investment alongside the management team to support the next phase of the company’s development.